Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease

Geriatrics and Gerontology International

Volumn 9, Issue 3, 2009, Pages 242-245

  Naito, Johji ^a   Naka, Yukiko ^a   Watanabe, Hirotoshi ^a  

^a Department of Pediatrics   (Japan)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Cognitive dysfunction; Dementia; Revised Hasegawa Dementia Scale

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COGNITION; CORRELATION ANALYSIS; DEMENTIA; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; REFERENCE VALUE; REVISED HASEGAWA DEMENTIA SCALE;

AGED; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN;

EID: 69249127155     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00526.x     Document Type: Article

References (13)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
2. Bonow RO. New insight into the cardiac natriuretic peptides. Circulation 1996; 93: 1946-1950.
3. Davis M, Espiner E, Richards G etal. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343: 440-444.
4. Nakagawa K, Yamaguchi T, Seida M et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 2005; 19: 157-164.
5. Gunstad J, Poppas A, Smeal S etal. Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55years of age with cardiovascular disease. Am J Cardiol 2006; 98: 538-540.
6. Kim KW, Lee DY, Jhoo JH et al. Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease. Dement Geriatr Cogn Disord 2005; 19: 324-330.
7. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
8. Naito J, Masuyama T, Tanouchi J et al. Analysis of transmural trend of myocardial integrated ultrasound backscatter for differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1994; 24: 517-524.
9. Abdulla HM. The natriuretic peptides: Universal volume controllers. Med Hypotheses 2001; 56: 451-453.
10. Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep 2008; 8: 371-376.
11. Espiner EA, Leikis R, Ferch RD et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf) 2002; 56: 629-635.
12. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
13. Moertl D, Berger R, Huelsmann M, Bojic A, Pacher R. Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure. Eur J Heart Fail 2005; 7: 1156-1163.